# Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

> **NCT00225199** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 198 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Visanne (BAY86-5258, SH T00660AA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00225199
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2010-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225199, "Efficacy and Safety of SH T00660AA in Treatment of Endometriosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00225199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*